 |
Scientific Advisory Board
Edwin M Horwitz, MD, PhD
Chairman of the Scientific Advisory Board. Dr.
Horwitz received his MD and PhD (Biochemistry) from
Indiana University in 1988. He then completed
clinical training in Pediatrics and Pediatric
Hematology Oncology as well as his laboratory
postdoctoral training at Washington University in
St. Louis. He served on the faculty at Washington
University for one year before being recruited to
St. Jude Children’s Research Hospital in Memphis,
Tennessee. Dr. Horwitz currently serves as the
Director of Cell Therapy in the Division of Oncology
/ Blood & Marrow Transplantation at Children’s Hospital of
Philadelphia.
Having published over 75 papers on
stem cell transplantation and stem cell biology, Dr.
Horwitz is an internationally recognized authority
on mesenchymal stromal cells (MSCs). He reported the
first clinical bone marrow transplant for children
with severe osteogenesis imperfecta, a genetic
disorder of the mesenchymal-derived bone cells. He
was also the first investigator to infuse allogeneic
MSCs into patients. Dr. Horwitz’s current research
is focused on furthering our knowledge of the MSC
biology as well as advancing MSC therapy for
hematologic and non-hematologic disorders. Dr.
Horwitz is a member of many transplantation and cell
therapy societies and serves on the Executive Board
of the International Society for Cellular Therapy.
top
Prof. Arnon Nagler
Prof. Nagler received his M.D. certification from
the Hebrew University in 1977 and has received his
certification in Internal Medicine from the Israel
Board of Internal Medicine. He received his MSc.
certification in Cell Biology from the Tel Aviv
University in 1985 and his Hematology certification
from the Israel Board of Hematology in 1986.
Prof. Nagler completed a residency at the Hadassah
University Hospital between 1977-1978. Prof. Nagler
studied Internal Medicine and Hematology at the
Rambam Medical Center in Haifa between 1980-1984 and
1984-1986, respectively. Between 1984-85 he was
active in the Histology and Cell Biology Department
at the Tel Aviv University Sackler School of
Medicine and between 1985-86 at the Hematopoiesis
Research Laboratory, at the Rambam Medical Center.
Between 1986-90 he was a Research Associate in the
Stanford Medical Center Hematology Department. In
1991 he was a Visiting Scientist at the DNAX
Research Institute, Palo Alto, Ca. Between 1995-98
he was the Head of the Israel National Human
Umbilical Cord Blood Bank, at the Hadassah Medical
Center. From 1990 to 2000 he held the position of
Senior Physician in the Hadassah Medical Center’s
Department of Bone Marrow Transplantation. In 2000
Prof. Nagler was appointed Director of the Chaim
Sheba Medical Center Bone Marrow Transplantation
Department and Cord Blood Bank, and in 2003 the
Director of the Hematology Institute.
Prof. Nagler is a Professor of Medicine at Tel Aviv
University Sackler School of Medicine. Among other
awards he has received, in 1994 Prof. Nagler was
awarded the Naftali Award for Research. Prof. Nagler
is the author of numerous scientific articles, has
been published in peer-reviewed journals, and has
written chapters in medical books.
His major research interests are: Cord Blood
Biology, Adoptive Cell Mediated Immunotherapy, NK
and CTL Activity, Transplantation in
Hemato-Oncologic Malignancies, Fibrotic Disorders
and the role of Collagen Type I.
He is a member of: the American Society of
Hematology, The International Bone Marrow Transplant
Registry, the International Cord Blood, the American
Association of Blood Banking, the ISCT and other
organization
top
Jacob Michael Rowe, M.D., F.A.C.P.
Dr. Rowe received his undergraduate and medical
degrees from University College and University
College Hospital in London. He completed his
internship in London and did a fellowship in
hematology/oncology at the University of Rochester,
NY. Between 1981 and 1996 Dr. Rowe was Director of
Clinical Services of the Hematology Unit at the
University of Rochester Medical Center, Rochester,
NY. He was also the founding Director of the Bone
Marrow Transplant Program at the University of
Rochester. Since 1994 he has been Chief of
Department of Hematology and Bone Marrow
Transplantation at the Rambam Medical Center, Haifa,
Israel. Dr. Rowe is the incumbent Dresner Professor
of Hemato-oncology and Vice Dean for Clinical
Appointments at the Bruce Rappaport Faculty of
Medicine of the Technion, Israel Institute of
Technology and also is an Adjunct Professor at the
Department of Medicine of Northwestern University,
Chicago, IL.
Dr. Rowe has actively participated in a wide range
of national and international research projects and
initiatives. He is a former Chairman of the Leukemia
Committee of the Eastern Cooperative Oncology Group
(ECOG) and has developed and chaired many phase II
and III studies in leukemia, lymphoma and BMT. Dr.
Rowe is a frequent invited speaker or chairman at
international meetings and has published over 250
peer-reviewed articles, reviews and book chapters.
top
Prof. Ron Gonen, M.D
Prof. Gonen received his MD from Sackler Medical School in Tel-Aviv University. In
2002 he was appointed Associated Professor at the
Faculty of Medicine, Technion – Israel Institute of
Technology. Currently, Prof. Gonen is the Head of
the Department of Obstetrics and Gynecology at the
Faculty of Medicine.
Prof. Gonen is the Senior Deputy Chairman of the
Department of Obstetrics and Gynecology and the
Director of Maternal Fetal Medicine at the Bnai-Zion
Medical Center, Haifa, Israel.
In the years 1987-1989 he completed a Fellowship
program in Maternal Fetal Medicine at the University
of Toronto, Canada. In 1991 he received a diploma in
Health Management Administration from the University of Haifa.
Prof. Gonen is the author of 68 original articles, 2
chapters in Text Books, 27 presentations in
international conferences and numerous lectures in
national meetings.
top
Dr. Avinoam Kadouri
Dr. Kadouri is one of the leading scientists in
industrial biotechnology with a worldwide
reputation. He has 15 years’ experience as R&D
Director and worldwide Process Development Director
at Serono International. Dr. Kadouri is the former Chairman
of ACTIP (Animal Cell Technology Industrial
Platform), an important European Organization of the
major biotechnology companies in Europe. He is a
member of several Scientific Advisory Boards of
leading biotechnology companies in the US, Europe
and Israel.
Prior to working in the industry, Dr. Kadouri spent
many years in leading research institutes and at
universities as an Associate Professor. He has
published a large number of papers in life science
and biotechnology areas and holds several applied
patents. Dr. Kadouri is a key guest speaker in many
major international conferences in biotechnology in
the US and Europe.
top
Dr. Abraham Treves
Dr. Treves is a leading Israeli expert on
hematopoietic stem cells (HSCs) who has published
more than 80 scientific publications, holds ten
patents, and has successfully obtained FDA approval
for clinical trials of an HSC product. He received
his Ph.D. at the Weizmann Institute of Science and
is currently the Executive Deputy of Israel’s Sheba
Cancer Research Center. He has directed many
industry and academic R&D programs in stem cell
therapy, immunology, hematology and oncology.
Dr. Treves was the founder, President and CEO of
Gamida-Cell Ltd., an Israeli biotechnology company
working in the field of HSC expansion, and was
instrumental in obtaining FDA approval for clinical
trials of stem cell biopharmaceutical product. He
has substantial experience in regulatory affairs for
biological and cell therapy, in clinical trials and
in manufacturing cell products under GMP. He is a
member of the American Society of Hematology and the
American Society of Clinical Oncology.
top
|
